Agilent/$A
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Agilent
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Ticker
$A
Sector
Primary listing
NYSE
Employees
18,000
Headquarters
Website
Agilent Metrics
BasicAdvanced
$36bn
25.50
$4.98
1.22
$1.01
0.80%
Price and volume
Market cap
$36bn
Beta
1.22
52-week high
$160.27
52-week low
$108.35
Average daily volume
2.6m
Dividend rate
$1.01
Financial strength
Current ratio
2.099
Quick ratio
1.457
Long term debt to equity
45.465
Total debt to equity
47.108
Dividend payout ratio (TTM)
20.16%
Interest coverage (TTM)
16.55%
Profitability
EBITDA (TTM)
2,015
Gross margin (TTM)
52.74%
Net profit margin (TTM)
19.55%
Operating margin (TTM)
24.03%
Effective tax rate (TTM)
10.51%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
8.64%
Return on equity (TTM)
21.33%
Valuation
Price to earnings (TTM)
25.499
Price to revenue (TTM)
4.972
Price to book
5.03
Price to tangible book (TTM)
16.07
Price to free cash flow (TTM)
33.08
Free cash flow yield (TTM)
3.02%
Free cash flow per share (TTM)
3.841
Dividend yield (TTM)
0.79%
Forward dividend yield
0.80%
Growth
Revenue change (TTM)
9.11%
Earnings per share change (TTM)
22.67%
3-year revenue growth (CAGR)
0.90%
10-year revenue growth (CAGR)
5.85%
3-year earnings per share growth (CAGR)
3.12%
10-year earnings per share growth (CAGR)
13.57%
3-year dividend per share growth (CAGR)
4.96%
10-year dividend per share growth (CAGR)
8.87%
What the Analysts think about Agilent
Analyst ratings (Buy, Hold, Sell) for Agilent stock.
Agilent Financial Performance
Revenues and expenses
Agilent Earnings Performance
Company profitability
Agilent News
AllArticlesVideos
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
Business Wire·3 weeks ago
Agilent Technologies shares jump on earnings beat, Bank of America upgrade
Proactive Investors·3 weeks ago
Agilent, Unusual Machines, Best Buy And Other Big Stocks Moving Higher On Thursday
Benzinga·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs